Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

ECCO IBD Curriculum

6.7. Appreciates the importance of on-going disease monitoring to confirm efficacy.
Diagnostic Techniques and Monitoring e-Coursee-Course
Year: 2018
Authors: Johan Burisch, Dominik Bettenworth, Hannah Gordon, Eduards Krustins, and Bram Verstockt, Kostas Katsanos

This course has been developed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the diagnosis and management management of IBD patients.

After this case you will:

  • Be able to identify the ideal diagnostic technique in various situations
  • Be acquainted with several diagnostic options that can be used as guidance for clinical practice

Ultrasound and IBD - e-Coursee-Course
Year: 2015
Authors: Torsten Kucharzik and Fortunata Civitelli

This course is designed for gastroenterologists, paediatricians, surgeons and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). The intended result of this activity is increased competence and knowledge of the role of imaging techniques, particularly ultrasonography, in the diagnosis and follow-up of IBD patients.

Upon completion of this activity learners will:

  • Understand the role of ultrasonography (US) in the initial diagnostic work-up of suspected IBD
  • Be able to provide a comprehensive overview of normal and abnormal findings in bowel US, with a focus on IBD
  • Be able to understand the usefulness of bowel US in the follow-up of IBD, in assessing disease activity, response to therapy and monitoring disease progression and complications such as stenosis, fistulae and abscesses

'Mainstream' biologicals: When to use?6th Basic ECCO: EduCational COurse for Industry
Year: 2022
Authors: Jean-Frédéric Colombel
'Older' medication: Still useful?6th Basic ECCO: EduCational COurse for Industry
Year: 2022
Authors: Uri Kopylov
Summary content

An overview of the use of 5-ASA, steroids and immunomodulators in IBD 

Anti-IL 12/2320th IBD Intensive Course for Trainees
Year: 2022
Authors: Marc Ferrante
Summary content

Educational objectives:
1. To understand the role of IL-12 and IL-23 in the development of IBD
2. To review the pivotal UNITI and UNIFI trials
3. To review the place of ustekinumab in IBD therapy
4. To have an overview on practical modalities of ustekinumab therapy
5. To get insight in the anti-IL23 drugs that are in development

Anti-integrins20th IBD Intensive Course for Trainees
Year: 2022
Authors: James Lindsay
Summary content

Educational objectives:
1. To understand the mechanism of action of vedolizumab and other anti interns
2. To review the key phase III clinical data
3. To highlight studies from real world cohort and discuss the safety profile of Vedolizumab
4. To understand how to position Vedolizumab in clinical practice

JAK inhibitors20th IBD Intensive Course for Trainees
Year: 2022
Authors: Silvio Danese
Summary content

Educational objectives:
1. Learn about the mechanisms of action of tofacitinib
2. Understand the clinical and endoscopic efficacy of tofacitinib in UC
3. Discuss the safety profile of tofacitinib

Therapeutic Drug Monitoring20th IBD Intensive Course for Trainees
Year: 2022
Authors: Filip J. Baert; Pascal Juillerat
Summary content

Learning Objectives:
1. Optimisation, Therapeutic Drug Monitoring of biological
2. Management of anti-drug-antibodies, allergic reaction
3. Strategies PRO / RE-active

CD Management11th N-ECCO School
Year: 2020
Authors: Marieke Pierik
UC Management11th N-ECCO School
Year: 2020
Authors: Mark Samaan
Transatlantic Talking Heads: Therapeutic Drug Monitoring and IBDTransatlantic Talking Heads
Year: 2019
Authors: Adam Cheifetz, Pascal Juillerat, Mark Osterman
Interpreting blood results (TGN, IGRA, TNF levels abnormal LFT, importance of TDM) 12th N-ECCO Network Meeting
Year: 2018
Authors: Irving Peter
N-ECCO_05
Files: 1
Personalising TherapyEducational Audio Podcast
Year: 2018
Authors: Henit Yanai
Anti-TNF agents15th IBD Intensive Advanced Course
Year: 2017
Authors: Baert F.
Anti TNF drug levels, Anti drug antibodies, Therapeutic drug monitoring, Anti-TNF agents
Files: 1
Case-based discussion: The patient with severe inflammatory Crohn’s Disease15th IBD Intensive Advanced Course
Year: 2017
Authors: Hindryckx P., Egan L.
Anti-TNF agents, Corticosteroids, Ustekinumab, Vedolizumab
Files: 1
Methotrexate15th IBD Intensive Advanced Course
Year: 2017
Authors: Juillerat P.
Crohn's disease, Ulcerative colitis, Therapeutic drug monitoring, Methotrexate
Files: 1
Thiopurines15th IBD Intensive Advanced Course
Year: 2017
Authors: Irving P.
Pharmacogenetics, Pharmacokinetics, Thiopurines (AZA/MP)
Files: 1
Ustekinumab15th IBD Intensive Advanced Course
Year: 2017
Authors: Ferrante M.
Crohn's disease, Disease activity Indices, Ustekinumab, Colonoscopy
Files: 1
Vedolizumab15th IBD Intensive Advanced Course
Year: 2017
Authors: Lindsay J.
Therapeutic drug monitoring, Vedolizumab
Files: 1
Under what circumstances can Faecal Calprotectin replace colonoscopyTalking Heads
Year: 2016
Authors: Iris Dotan, Edouard Louis, Patrick van Rheenen